California's multi-billion-dollar biotech industry is taking in Thursday's landmark Supreme Court ruling on human genes. In short, naturally occurring genes are not patentable. It's a major shift for biotech companies -- but it's one they're prepared for.
upper waypoint
lower waypoint
next waypoint
To learn more about how we use your information, please read our privacy policy.
